TP53 and cervical cancer: Blocking HPV16 E6 or caspase-8 binding reportedly increases the level of caspase-8 and p53 in cervical cancer SiHa cells, resulting in an increase in caspase-3 and -7 activity, but this was not effective in HPV-negative cervical or oral cancer cells [28].